Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Equity Income (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Equity Income for 8 consecutive years, with $12.5 million as the latest value for Q1 2025.

  • On a quarterly basis, Equity Income rose 20.07% to $12.5 million in Q1 2025 year-over-year; TTM through Mar 2025 was $62.3 million, a 46.02% increase, with the full-year FY2025 number at $54.5 million, down 9.48% from a year prior.
  • Equity Income was $12.5 million for Q1 2025 at Select Medical Holdings, up from $10.4 million in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $33.1 million in Q3 2024 to a low of $5.4 million in Q1 2022.
  • A 5-year average of $10.8 million and a median of $10.4 million in 2024 define the central range for Equity Income.
  • Peak YoY movement for Equity Income: surged 283.27% in 2021, then crashed 47.78% in 2022.
  • Select Medical Holdings' Equity Income stood at $11.2 million in 2021, then tumbled by 39.91% to $6.8 million in 2022, then soared by 50.84% to $10.2 million in 2023, then grew by 2.24% to $10.4 million in 2024, then rose by 20.04% to $12.5 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Equity Income are $12.5 million (Q1 2025), $10.4 million (Q4 2024), and $33.1 million (Q3 2024).